- Revenues of $1.007 Billion
- GAAP Net Loss Attributable to Bausch + Lomb Corporation of $84 Million
- Adjusted EBITDA (non-GAAP)1 of $187 Million
- Revenues Grew 7% as Reported and 8% on a Constant Currency1 Basis Compared to the Third Quarter of 2022, Driven by Growth in the Vision Care and Surgical Segments
- Foreign Exchange Negatively Impacted Revenues and Adjusted EBITDA (non-GAAP)1 by Approximately $10 Million and $14 Million, Respectively
- Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP)1 Guidance
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.